Assessment of tumoral heterogeneity in NSCLC treated with bevacizumab: A prospective study.
2014
e19124 Background: Imaging heterogeneity may reflect biological heterogeneity. Changes in tumoral heterogeneity in NSCLC treated with chemotherapy ± bevacizumab in a prospective study, and their as...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI